Abstract:Background: Alcoholic liver disease (ALD) is a leading cause of advanced liver disease; however, minor clinical symptoms in the early stage frequently result in delayed diagnosis and therapy. Invasive liver biopsy, the gold standard for diagnosing ALD, is unsuitable for repetitive analysis. This study aims to identify potential serum biomarkers that could contribute to non-invasive disease screening and monitoring. Methods: Label-free LC-MS/MS quantitative proteomics analysis was performed to identify differentially expressed proteins in the discovery cohort, followed by bioinformatics analysis based on the KEGG, GO, and String databases. Prioritized proteins were validated subsequently by quantitative assays. The area under the receiver operating characteristic curve (AUROC) was used to assess the diagnosis performance of potential biomarkers. Results: A total of 161 differentially expressed proteins were identified in the discovery cohort, of which 123 were up-regulated and 38 were down-regulated. B2M, IGFALS, and IGFBP3 were evaluated, and all demonstrated excellent diagnosis performance with AUROCs of over 0.9 when distinguishing patients with severe ALD from healthy controls. The AUROC values of B2M, IGFBP3, and IGFALS were 0.7131, 0.8877, and 0.9896 for differentiating severe ALD from non-severe ALD to indicate disease severity. B2M could distinguish patients with non-severe ALD and HC participants with an AUROC value of 0.8985. The efficiency of multiple combinations of these biomarkers was superior to that of the existing liver fibrosis evaluation indices used to monitor disease progression, with AUROC values of over 0.9. IGFALS showed a positive correlation with ALT/AST (r=0.4648, P=0.0009) and may be developed as a therapeutic target. Conclusion: This proteomic study identified three novel candidate proteins as promising circulating biomarkers for clinical diagnosis and disease progression and also provided the proteomic atlas for ALD pathophysiological mechanisms.

Circulating MicroRNAs As Potential Biomarkers for Alcoholic Steatohepatitis.

Pattern of Microrna Expression Associated with Different Stages of Alcoholic Liver Disease in Rat Models

Analysis of Differentially Expressed Genes and Micrornas in Alcoholic Liver Disease

Noncoding RNAs in Alcoholic Liver Disease

Diagnostic Accuracy of Circulating Micrornas for Hepatitis C Virus-Associated Hepatocellular Carcinoma: a Systematic Review and Meta-Analysis

Transition from hepatic steatosis to steatohepatitis: unique microRNA patterns and potential downstream functions and pathways.

MicroRNA expression pattern in different stages of nonalcoholic fatty liver disease.

Circulating miRNAs as Novel Diagnostic Biomarkers in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.

Aberrant Hepatic Microrna Expression in Nonalcoholic Fatty Liver Disease

miRNAs in patients with alcoholic liver disease: a systematic review and meta-analysis

Circulating MicroRNA Panel As a Diagnostic Marker for Hepatocellular Carcinoma

Circrna Expression Pattern And Circrna-Mirna-Mrna Network In The Pathogenesis Of Nonalcoholic Steatohepatitis

A serum metabonomic study on the difference between alcohol- and HBV-induced liver cirrhosis by ultraperformance liquid chromatography coupled to mass spectrometry plus quadrupole time-of-flight mass spectrometry.

Novel potential biomarkers for severe alcoholic liver disease

Blood Exosomal Micro Ribonucleic Acid Profiling Reveals the Complexity of Hepatocellular Carcinoma and Identifies Potential Biomarkers for Differential Diagnosis.

Circulating microRNA profiling identifies microRNAs linked to prediabetes associated with alcohol dependence syndrome

Disease-specific Mir-34A As Diagnostic Marker of Non-Alcoholic Steatohepatitis in a Chinese Population.

A Pilot Study of Serum MicroRNAs Panel as Potential Biomarkers for Diagnosis of Nonalcoholic Fatty Liver Disease

microRNAs and Other Serological Markers of Liver Fibrosis in Patients with Alcohol-Related Liver Cirrhosis

Identification of differentially expressed miRNAs and key genes involved in the progression of alcoholic fatty liver disease using rat models: DEGs in AFLD

Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies.